Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Thats a critical distinction, because it means these patches do not actually contain the active GLP-1 medications responsible for the weight-loss effects seen in clinical trials
Research from Worldpanel by Numerator found that the share of British households containing a GLP-1 user rose from 2.3% in 2024 to 6.3% in 2026
Newer systematic reviews and meta-analyses suggest a slight increase in pancreatitis overall, although this may not be significant once background medications are considered, and no clear increase in pancreatic cancer has been consistently shown
Market Segmentation Analysis Ready-to-drink shakes account for 31.0% of market revenue in 2026 as they fit the simplest daily-use meal replacement occasion
